Starting with Exelixis’ condition on in-house dispensing data, manufacturers are introducing a new approach to 340B claims focused on transparency.
|Articles|January 22, 2007
Heart attacks: From risk factors to drug compliance
Treating heart attacks and agents affecting risk factors for heart disease were among the hot topics explored at the American Heart Association's 2006 annual meeting held recently in Chicago. Also, a program on increasing adherence to pharmacotherapy among the elderly was of interest to attendees.
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Drug Topics
1
GLP-1 Therapy Must Prioritize Metabolic Quality Over Weight Loss
2
FDA Approves Update for Winrevair Based on Phase 3 HYPERION Trial Data
3
COVID-19 Vaccine Hesitancy in 2026: How Attitudes Have Shifted
4
PPV23 Vaccination Found to Not Reduce Cardiovascular Risk
5